Comparison of Block Characteristics and Rebound Pain Characteristics in Perineural Dexamethasone–Perineural Dexmedetomidine versus Intravenous Dexamethasone–Perineural Dexmedetomidine as Adjuvants to 0.5% Levobupivacaine in Ultrasound-Guided Axillary Brachial Plexus Block for Upper Limb Surgeries
International Journal of Drug Delivery Technology · 12.06.2026 · 16 (53s)
DOI: 10.25258/ijddt.16.53s.80 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 12.06.2026. Verfasst von Thiriloga Sundary Murali Rajagopalan und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Perineural dexmedetomidine prolongs brachial plexus block but its abrupt offset is associated with rebound pain. Dexamethasone, administered perineurally or intravenously, may modulate this effect, yet the optimal route when combined with dexmedetomidine remains unclear.
Aim
To compare block characteristics and rebound pain between perineural dexamethasone and intravenous dexamethasone, both combined with perineural dexmedetomidine, as adjuvants to 0.5% levobupivacaine in ultrasound-guided axillary brachial plexus block.
Methods
Sixty adults (ASA I–II) scheduled for upper limb surgery were randomised into two groups (n=30). Group PD received 25 mL of 0.5% levobupivacaine with perineural dexmedetomidine 1 µg/kg and perineural dexamethasone 0.1 mg/kg plus IV saline. Group IVD received the same local anaesthetic with perineural dexmedetomidine 1 µg/kg plus IV dexamethasone 0.1 mg/kg and perineural saline. Outcomes included onset and duration of sensory and motor block, duration of analgesia, incidence and severity of rebound pain, 24-hour analgesic consumption and adverse events.
Results
Block onset and demographic profile were comparable. Sensory and motor block durations were longer in Group PD, whereas total duration of analgesia was longer in Group IVD (21.4 ± 2.5 h vs 19.2 ± 2.3 h; p = 0.001). Rebound pain incidence was significantly lower in Group IVD (23.3% vs 56.7%; p = 0.009), as were peak rebound NRS (3.6 ± 1.0 vs 6.2 ± 1.3; p < 0.001) and 24-hour tramadol consumption.
Conclusion
Adding intravenous dexamethasone to perineural dexmedetomidine produced superior analgesia and markedly attenuated rebound pain compared with the dual perineural regimen, supporting the systemic route for dexamethasone in this combination
Zitieren
APA
Rajagopalan, T. S. M., Kalyanaraman, P., Kalaimani, K., & Jeevaratnam, R. (2026). Comparison of Block Characteristics and Rebound Pain Characteristics in Perineural Dexamethasone–Perineural Dexmedetomidine versus Intravenous Dexamethasone–Perineural Dexmedetomidine as Adjuvants to 0.5% Levobupivacaine in Ultrasound-Guided Axillary Brachial Plexus Block for Upper Limb Surgeries. International Journal of Drug Delivery Technology, 16(53s). https://doi.org/10.25258/ijddt.16.53s.80
Vancouver
Rajagopalan TSM, Kalyanaraman P, Kalaimani K, Jeevaratnam R. Comparison of Block Characteristics and Rebound Pain Characteristics in Perineural Dexamethasone–Perineural Dexmedetomidine versus Intravenous Dexamethasone–Perineural Dexmedetomidine as Adjuvants to 0.5% Levobupivacaine in Ultrasound-Guided Axillary Brachial Plexus Block for Upper Limb Surgeries. International Journal of Drug Delivery Technology. 2026;16(53s). doi:10.25258/ijddt.16.53s.80
BibTeX
@article{Rajagopalan2026,
author = {Rajagopalan, Thiriloga Sundary Murali and Kalyanaraman, Prasanna and Kalaimani, Keerthana and Jeevaratnam, Revathy},
title = {Comparison of Block Characteristics and Rebound Pain Characteristics in Perineural Dexamethasone–Perineural Dexmedetomidine versus Intravenous Dexamethasone–Perineural Dexmedetomidine as Adjuvants to 0.5% Levobupivacaine in Ultrasound-Guided Axillary Brachial Plexus Block for Upper Limb Surgeries},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {53s},
doi = {10.25258/ijddt.16.53s.80}
}
EUVIMED